Technical analysis of aTyr Pharma, Inc. (ATYR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2.
Price Performance
| 1 month | -23.80% |
| 3 months | -14.74% |
| Year-to-date | -50.95% |
| 1 year | -62.34% |
52-Week Range
| 52-week High | $1.20 |
| 52-week Low | $0.38 |
| Avg Volume (90d) | 2.1M |
Technical Indicators
| SMA 50 | $0.50 |
| SMA 200 | $0.69 |
| Beta | 0.65 |
| 30-day Volatility (annualised) | 68.6% |
| Price vs SMA 50 | -23.9% |
| Price vs SMA 200 | -44.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $0.87 | |
| 2025-11 | $0.78 | -9.9% |
| 2025-12 | $0.78 | +0.3% |
| 2026-01 | $0.88 | +12.7% |
| 2026-02 | $0.96 | +8.7% |
| 2026-03 | $0.78 | -18.7% |
| 2026-04 | $0.81 | +3.5% |
| 2026-05 | $0.54 | -32.8% |
| 2026-06 | $0.60 | +10.0% |
| 2026-07 | $0.49 | -18.6% |
| 2026-08 | $0.53 | +9.5% |
| 2026-09 | $0.38 | -27.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | $563M |
| 2026-09-14 | | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $0.20 | $23M |
| 2026-09-14 | | |
Price
| Price | $0.38 |
| Market Cap | $38M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.72 |
| EV / EBITDA | -1.02 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.23 |
| Current Ratio | 5.12 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -9.28 |